Press Release – New York, NY – October 31, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Thumzup Media Corporation (OTCQB: TZUP) (NASDAQ: TZUP), a leading provider of …
Sichenzia Ross Ference Carmel LLP represents INmune Bio Inc. in $13.0 Million Registered Direct Offering
Press Release – New York, NY – September 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio (Nasdaq: INMB), a clinical-stage inflammation and immunology …
Sichenzia Ross Ference Carmel LLP 代表 Sharps Technology, Inc. 完成 350 万美元过桥融资
新闻稿 – 纽约州纽约 – 2024 年 9 月 24 日 – Sichenzia Ross Ference Carmel LLP 今天宣布，它代表 Sharps Technology, Inc.（纳斯达克股票代码：STSS），这是一家创新型医疗器械和药品包装公司，提供一流的专利技术注射器产品，在其先前宣布的约 350 万美元的过桥融资结束时。 Aegis Capital …
Continue Reading about Sichenzia Ross Ference Carmel LLP 代表 Sharps Technology, Inc. 完成 350 万美元过桥融资 →
Sichenzia Ross Ference Carmel LLP Represents Sharps Technology, Inc. in Closing of $3.5 Million Bridge Financing
Press Release – New York, NY – September 24, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sharps Technology, Inc. (NASDAQ: STSS), an innovative medical device and …
Sichenzia Ross Ference Carmel LLP Represents Impact Biomedical Inc. in Closing of $4.5 Million Initial Public Offering
Press Release – New York, NY – September 18, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Impact Biomedical Inc. (NYSE: IBO), a company discovering and developing new …
Sichenzia Ross Ference Carmel LLP Represents Qualigen Therapeutics, Inc. in $3.47 Million Public Offering
Press Release - New York, NY - September 6, 2024 - Sichenzia Ross Ference Carmel LLP announced that it has represented Qualigen Therapeutics, Inc. in the pricing of its $3.47 million public …
